Mirum Pharmaceuticals (MIRM) Intangibles (2021 - 2026)

Mirum Pharmaceuticals' Intangibles history runs 6 years deep, the most recent figure standing at $254.2 million for Q1 2026.

• In Q1 2026, Intangibles rose 4.23% year-over-year to $254.2 million; the TTM figure through Mar 2026 stood at $254.2 million (up 4.23% YoY), while the FY2025 annual figure was $260.9 million, up 4.44% from the prior year.
• Intangibles was $254.2 million for Q1 2026 at Mirum Pharmaceuticals, down from $260.9 million in the prior quarter.
• In the past five years, Intangibles ranged from a high of $261.8 million in Q2 2024 to a low of $18.5 million in Q1 2022.
• Historically, Intangibles has averaged $179.3 million across 5 years, with a median of $243.8 million in 2025.
• The sharpest annual moves came in 2023 and 2025: Intangibles jumped 473.68% in 2023, then dropped 9.34% in 2025.
• A 5-year view of Intangibles shows it stood at $59.0 million in 2022, then surged by 329.02% to $252.9 million in 2023, then declined by 1.23% to $249.8 million in 2024, then climbed by 4.44% to $260.9 million in 2025, then dropped by 2.59% to $254.2 million in 2026.
• The last three Intangibles figures came in at $254.2 million (Q1 2026), $260.9 million (Q4 2025), and $231.9 million (Q3 2025), per Business Quant data.